MIRA
NASDAQ · Pharmaceuticals
Mira Pharmaceuticals Inc
$0.57
+0.03 (+5.70%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,933.3% upside
Low Target
$12.17
Average Target
$23.03
High Target
$29.15
Current Price
$0.57
Current
$0.57
$0.57
Target
$23.03
$23.03
$12.17
$23.03 avg
$29.15
Scenario Analysis
Bear Case
$12.17
2,031.3%
Low target
Base Case
$23.03
+3,933.3%
Avg target
Bull Case
$29.15
+5,005.1%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$1.69
-66.2% from high
52-Week Low
$0.51
+12.0% from low
Target vs 52W High
$23.03
+1,262.7% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.03
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals